Assyro AI

Orange Book product · Brand (NDA)

JAVADIN

CLONIDINE HYDROCHLORIDE

Brand (NDA)NDA 220256RX AZURITY

At a glance

Oct 23, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 23, 2025

    8 mo ago

  2. Today

  3. Patent 12233049 expires

    Listed drug product patent expiration.

    Jul 15, 2042

    in 16 yr 4 mo

  4. Patent 12440474 expires

    Listed drug product patent expiration.

    Jul 15, 2042

    in 16 yr 4 mo

Pharmaceutical detail

Active ingredient

CLONIDINE HYDROCHLORIDE

Strength

0.02MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 220256

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12233049Jul 15, 2042in 16 yr 4 mo
Product
12440474Jul 15, 2042in 16 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.